Momenta Pharmaceuticals

Industry / private company


Location: Cambridge, MA, United States (USA) (US) US

ISNI: 0000000404102872

ROR: https://ror.org/01xdkk717

Show on Map:

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitors. (2016) Ortiz DF, Lansing JC, Rutitzky L, Kurtagic E, Prod'Homme T, Choudhury A, Washburn N, et al. Journal article Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity. (2015) Washburn N, Schwab I, Ortiz D, Bhatnagar N, Lansing JC, Medeiros A, Tyler S, et al. Journal article